Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16298557 | 0.91 | ALDH1A1 (0.48) | TDP1ALDH1A1CASP1CYP3A4MAPT | |
| SCHEMBL10002180 | 0.78 | — | — | |
| SCHEMBL3690091 | 0.73 | LPL (0.46) | TDP1ALDH1A1CASP1CYP3A4 | |
| SCHEMBL7860034 | 0.72 | ALDH1A1 (0.39) | TDP1ALDH1A1CYP3A4TSHRSMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL31547133 | 0.71 | LPL (0.44) | TDP1ALDH1A1CASP1CYP3A4 | |
| SCHEMBL16298593 | 0.71 | TDP1 (0.41) | TDP1ALDH1A1CASP1CYP3A4MAPT | |
| SCHEMBL10002183 | 0.68 | POLB (0.32) | — | |
| SCHEMBL7858597 | 0.62 | TDP1 (0.41) | TDP1ALDH1A1CYP3A4KDM4ESMN1; SMN2 | |
| SCHEMBL7859991 | 0.62 | TDP1 (0.41) | TDP1ALDH1A1CYP3A4KDM4ESMN1; SMN2 | |
| SCHEMBL3780980 | 0.61 | CYP3A4 (0.45) | TDP1ALDH1A1CASP1CYP3A4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120016146-A1 | POROUS CRYSTAL COMPRISING AMMONIA BORANE AND A PRODUCTION METHOD THEREFOR | INSILICOTECH CO., LTD (KR) | 2012-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120016146-A1 | POROUS CRYSTAL COMPRISING AMMONIA BORANE AND A PRODUCTION METHOD THEREFOR | FAR1, GOT1, WEE1 | TDP1 3778/4885ALDH1A1 2659/4885CASP1 1784/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.